Association of cancer and Alzheimer's disease risk in a national cohort of veterans

Abstract
Introduction To examine the risk of Alzheimer's disease (AD) among cancer survivors in a national database. Methods Retrospective cohort of 3,499,378 mostly male US veterans aged ≥65 years were followed between 1996 and 2011. We used Cox models to estimate risk of AD and alternative outcomes (non‐AD dementia, osteoarthritis, stroke, and macular degeneration) in veterans with and without a history of cancer. Results Survivors of a wide variety of cancers had modestly lower AD risk, but increased risk of the alternative outcomes. Survivors of screened cancers, including prostate cancer, had a slightly increased AD risk. Cancer treatment was independently associated with decreased AD risk; those who received chemotherapy had a lower risk than those who did not. Discussion Survivors of some cancers have a lower risk of AD but not other age‐related conditions, arguing that lower AD diagnosis is not simply due to bias. Cancer treatment may be associated with decreased risk of AD.
Funding Information
  • National Institutes of Health (T32 NS048005)
  • Harvard NeuroDiscovery Center
  • Harvard Catalyst (UL1 TR001102)